Skip to content
Recall Observatory FDA recall evidence

Drug product

Irbesartan Tablets USP, 75 mg a) 30 count (NDC 68180-410-06) and b) 90 count (NDC 68180-410-09) bottles, Rx only

D-0086-2022

October 12, 2021

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 88856
Status
Terminated
Classification
Class II
Quantity
51,144 bottles
Official record key
drug-enforcement:D-0086-2022

Official wording

Reason: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Code information: a) Lot# H000843, exp. date 28/02/2023 H805727, exp. date 30/11/2021 H901579, exp. date 31/03/2022 b) Lot# H000844, exp. date 28/02/2023 H000964, exp. date 31/03/2023 H804311, exp. date 31/08/2021 H805267, exp. date 30/11/2021 H805268, exp. date 30/11/2021 H805269, exp. date 30/11/2021 H805725, exp. date 30/11/2021 H805726, exp. date 30/11/2021 H901497, exp. date 31/01/2022 H901577, exp. date 31/03/2022 H901578, exp. date 31/03/2022 H902258, exp. date 31/05/2022

Distribution pattern: Product was distributed to major distributors who may have further distributed the product nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity N-nitrosoirbesartan detected in API
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations